Procter&Gamble Standalone December 2021 Net Sales at Rs 277.90 crore, up 15.69% Y-o-Y
February 25, 2022 / 09:45 AM IST
Reported Standalone quarterly numbers for Procter & Gamble Health are:Net Sales at Rs 277.90 crore in December 2021 up 15.69% from Rs. 240.22 crore in December 2020.
Quarterly Net Profit at Rs. 44.84 crore in December 2021 down 33.94% from Rs. 67.88 crore in December 2020.
EBITDA stands at Rs. 66.54 crore in December 2021 down 29.56% from Rs. 94.47 crore in December 2020.
Procter&Gamble EPS has decreased to Rs. 27.00 in December 2021 from Rs. 40.90 in December 2020.
Procter&Gamble shares closed at 4,542.95 on February 24, 2022 (NSE) and has given -16.48% returns over the last 6 months and -33.82% over the last 12 months.
| Procter & Gamble Health | | Standalone Quarterly Results | in Rs. Cr. |
|
| Dec'21 | Sep'21 | Dec'20 | | Net Sales/Income from operations | 277.90 | 272.80 | 240.22 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 277.90 | 272.80 | 240.22 | | EXPENDITURE | | Consumption of Raw Materials | 91.63 | 92.99 | 46.67 | | Purchase of Traded Goods | 5.24 | 6.51 | 4.26 | | Increase/Decrease in Stocks | -6.53 | -16.97 | 12.65 | | Power & Fuel | -- | -- | -- | | Employees Cost | 41.00 | 39.51 | 33.49 | | Depreciation | 6.59 | 6.90 | 7.85 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 84.72 | 72.69 | 54.40 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | 55.25 | 71.17 | 80.90 | | Other Income | 4.70 | 3.04 | 5.72 | | P/L Before Int., Excpt. Items & Tax | 59.95 | 74.21 | 86.62 | | Interest | 0.12 | 0.14 | 0.19 | | P/L Before Exceptional Items & Tax | 59.83 | 74.07 | 86.43 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | 59.83 | 74.07 | 86.43 | | Tax | 14.99 | 18.70 | 18.55 | | P/L After Tax from Ordinary Activities | 44.84 | 55.37 | 67.88 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 44.84 | 55.37 | 67.88 | | Equity Share Capital | 16.60 | 16.60 | 16.60 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 27.00 | 33.40 | 40.90 | | Diluted EPS | 27.00 | 33.40 | 40.90 | | EPS After Extra Ordinary | | Basic EPS | 27.00 | 33.40 | 40.90 | | Diluted EPS | 27.00 | 33.40 | 40.90 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
